-
Signature
-
/s/ Danika Haueisen, Attorney-In-Fact for Julie Spellman Sweet
-
Issuer symbol
-
ACN
-
Transactions as of
-
10 Feb 2026
-
Net transactions value
-
-$1,461,102
-
Form type
-
4
-
Filing time
-
10 Feb 2026, 17:07:10 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Sweet Julie Spellman |
Chair and CEO, Director |
C/O ACCENTURE, 500 W. MADISON STREET, CHICAGO |
/s/ Danika Haueisen, Attorney-In-Fact for Julie Spellman Sweet |
10 Feb 2026 |
0001487630 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ACN |
Class A ordinary shares |
Sale |
$51,236 |
-217 |
-1% |
$236.11 |
21,095 |
10 Feb 2026 |
Direct |
F1 |
| transaction |
ACN |
Class A ordinary shares |
Sale |
$68,658 |
-288 |
-1.4% |
$238.39 |
20,807 |
10 Feb 2026 |
Direct |
F1, F2 |
| transaction |
ACN |
Class A ordinary shares |
Sale |
$104,278 |
-435 |
-2.1% |
$239.72 |
20,372 |
10 Feb 2026 |
Direct |
F1, F3 |
| transaction |
ACN |
Class A ordinary shares |
Sale |
$443,970 |
-1,843 |
-9% |
$240.90 |
18,529 |
10 Feb 2026 |
Direct |
F1, F4 |
| transaction |
ACN |
Class A ordinary shares |
Sale |
$544,220 |
-2,251 |
-12% |
$241.77 |
16,278 |
10 Feb 2026 |
Direct |
F1, F5 |
| transaction |
ACN |
Class A ordinary shares |
Sale |
$248,740 |
-1,023 |
-6.3% |
$243.15 |
15,255 |
10 Feb 2026 |
Direct |
F1, F6 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: